Navigation Links
Schering-Plough CEO Buys $2 Million in Common Shares
Date:4/24/2008

KENILWORTH, N.J., April 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced today that Chairman and CEO Fred Hassan purchased just over $2 million of Schering-Plough common stock, or 110, 000 shares at an average purchase price of $18.26 per share.

"As I said when I announced my intention to purchase these shares in January, this investment in Schering-Plough reflects my long-term confidence in the company, its products -- including ZETIA and VYTORIN -- and our late- stage pipeline," said Hassan.

Hassan has said on January 18 that he intended to purchase the shares as soon as the transaction received legal clearance. That clearance was issued this morning, based upon first quarter earnings having been reported yesterday.

Full details of the purchase will be reported on a Form 4 filed with the SEC and available on Schering-Plough's Web site today or tomorrow.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe
2. Schering-Plough Reports Financial Results for First Quarter of 2008
3. Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
4. Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
5. Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
6. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
7. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
8. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
9. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
10. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
11. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...and accountability is the way of life at Meriter ...pital in Madison that provides medical care to sou...ic, retirement living facility, laboratories and a... Madison General Hospital and Methodist Hospital i...associate physicians in over 30 medical specialtie...
...t week of August, those seven days in which we att...ous three months. For me, this week also signals ...eading to San Diego for DEMOmobile 2004. (Its a gr... yet, youd better do so now.) In truth, I should ...ntroductions, but as an inveterate procrastinator,...
...gh school, you studied hard to get the right answe... you tried hard to say the right thing. , ,Through...d and learned so you can excel in your field and d... on you! Sometimes, for some Midwest high-tech wor...king about a subspecies of the genus Bossus Horrib...
... Children,s Hospital announced on Tuesday that th...l Systems Ltd. to purchase the information system ...olumbus Children,s Heart Center , which addresses...heart defects. , ,The choice was based on an in-de...cal needs, looking specifically at the issue of ac...
Other Biology Technology:Meriter IT team builds project performance through internal relationships 2Meriter IT team builds project performance through internal relationships 3Meriter IT team builds project performance through internal relationships 4Wrapping up the Summer 2Wrapping up the Summer 3Wrapping up the Summer 4How to thwart the dont-be-right Midwest technology boss 2How to thwart the dont-be-right Midwest technology boss 3How to thwart the dont-be-right Midwest technology boss 4Children's Hospital chooses Camtronics for cardiology IT system 2
(Date:7/24/2008)...sses embedded with a telescope promise to make it ...d do other activities requiring sharper distance v...describe the advantages of these innovative glasse...the May/June issue of Journal of Biomedical Optic...h. , "This new design has several advantages," ...
(Date:7/24/2008)...y 24, 2008 A new study by researchers from Columb...dresses one of the most challenging issues in infa...mission in poor countries. In these settings, HIV...st outcome for their infants, they should exclusiv...to six months after birth. But according to the st...
(Date:7/24/2008)...earchers at The Pennsylvania State University Coll...ered that the efficacy of imiquimod, a clinically ...iviral and antitumor activity, is dependent on the...is for its action. This discovery, reported in th...icine , provides new insights into a widely used d...
(Date:7/24/2008)...BRIDGE, Mass. -- Scientists at Harvard University ...hat genetic evolution is strongly shaped by genes,...production. , Their study also suggests that the...he malformed proteins themselves, rather than the ...n build up in long-lived cells, like neurons, and ...
Breaking Biology News(10 mins):Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3Nikon Instruments Partners With Koshland Science Museum to Create the Museums First Ever Microbe Lab 2596 1Nikon Instruments Partners With Koshland Science Museum to Create the Museums First Ever Microbe Lab 2596 2Nikon Instruments Partners With Koshland Science Museum to Create the Museums First Ever Microbe Lab 2596 3CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 2594 1CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 2594 2CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 2594 3PennWell Launches Bio Optics World Magazine and Web Site 2592 1PennWell Launches Bio Optics World Magazine and Web Site 2592 2PennWell Launches Bio Optics World Magazine and Web Site 2592 3Healthcare Technologies Ltd 28NASDAQ 3A HCTL 29 Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants 2590 1Healthcare Technologies Ltd 28NASDAQ 3A HCTL 29 Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants 2590 2
...soils that inhibit a tiny soybean-destroying organ... according to a Purdue University plant pathologis...lion and $1 billion annually in crop losses in the...ogical Society. However, techniques are available ...roscopic roundworms, said Andreas Westphal, assist...
...d as medical waste, placental tissue could feasibl...e potential to treat diseases and regenerate tissu...onic stem cells, suggests a University of Pittsbur... and available now as an early online publication ...lled the amnion, or the outer membrane of the amni...
...ologists at the University of California, Berkeley... chain reaction that leads to the increased expres...ystem. , The new findings, to be published July 3 ...on a long-standing question of how the natural kil... can differentiate cells that are cancerous from t...
...o Reactor number 4 at Chernobyl exploded, sending ... Ukraine, Belarus, and Russia. Some 40 radionucleo...g Strontium 90 (90Sr) and Cesium 137 (137Cs). Yet ... natural areas in the region have rebounded, and b...The session, organized by James Morris and Timothy...
Other Biology News:Techniques available to detect soil that inhibits destructive soybean pest 2Techniques available to detect soil that inhibits destructive soybean pest 3Discarded placentas deliver researchers promising cells similar to embryonic stem cells 2Discarded placentas deliver researchers promising cells similar to embryonic stem cells 3Discarded placentas deliver researchers promising cells similar to embryonic stem cells 4Renewed hope for Parkinson's patients 2Renewed hope for Parkinson's patients 3The ecological effects of the Chernobyl disaster 2The ecological effects of the Chernobyl disaster 3
Proteinase K Buffer 3.9 ml
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454
Glutathione Agarose Beads 10 ml
Biology Products: